This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brackett, D. J. Articles by Pereira, H. A. Search for Related Content PubMed PubMed Citation Articles by Brackett, D. J. Articles by Pereira, H. A.

 Previous Article  |  Next Article 

Infect. Immun., Jul 1997, 2803-2811, Vol 65, No. 7
Copyright © 1997, American Society for Microbiology

A synthetic lipopolysaccharide-binding peptide based on the neutrophil- derived protein CAP37 prevents endotoxin-induced responses in conscious rats

DJ Brackett, MR Lerner, MA Lacquement, R He and HA Pereira
Department of Surgery, University of Oklahoma Health Sciences Center, and Department of Veterans Affairs Medical Center, Oklahoma City 73190, USA.

The lipid A component of lipopolysaccharide (LPS) derived from Escherichia coli has been implicated as a significant mediator in the development of circulatory and metabolic dysfunction and lethality associated with sepsis. A synthetic peptide corresponding to amino acid residues 20 through 44 of the neutrophil-derived 37-kDa cationic antimicrobial protein (CAP37 P(20-44)) possesses lipid A binding characteristics which may be useful in attenuating in vivo responses induced during circumstances of endotoxemia, including sepsis. The E. coli LPS to be used in the in vivo study was shown to be attenuated by CAP37 P(20-44) in a dose-dependent manner in the in vitro reaction with Limulus amoebocyte lysate. Intravenous infusion of CAP37 P(20-44) (1.5 or 3.0 mg/kg of body weight) with E. coli LPS (250 microg/kg over 30 min) into conscious, unrestrained rats prevented LPS-induced hyperdynamic and hypodynamic circulatory shock, hyperlactacidemia, and leukopenia in a dose-related fashion. CAP37 P(20-44) (0.2, 1.0, and 5.0 mg/kg) administered intravenously to conscious, actinomycin D- sensitized rats following a lethal dose of LPS neutralized LPS toxicity, resulting in dose-dependent 7-day survival rates of 30, 50, and 80%, respectively. CAP37 P(20-44) (5.0 mg/kg) significantly inhibited the endotoxin-induced increase in circulating tumor necrosis factor alpha in sensitized rats. These data demonstrate that CAP37 P(20- 44) has the capacity to abolish in vivo biological responses to LPS that are relevant to human sepsis and to significantly neutralize the toxicity of circulating E. coli LPS.

This article has been cited by other articles:

• Jacobsen, F., Baraniskin, A., Mertens, J., Mittler, D., Mohammadi-Tabrisi, A., Schubert, S., Soltau, M., Lehnhardt, M., Behnke, B., Gatermann, S., Steinau, H. U., Steinstraesser, L. (2005). Activity of histone H1.2 in infected burn wounds. J Antimicrob Chemother 55: 735-741 [Abstract] [Full Text]  
• Van Amersfoort, E. S., Van Berkel, T. J. C., Kuiper, J. (2003). Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock. Clin. Microbiol. Rev. 16: 379-414 [Abstract] [Full Text]  
• Bosshart, H., Heinzelmann, M. (2002). Arginine-Rich Cationic Polypeptides Amplify Lipopolysaccharide-Induced Monocyte Activation. Infect. Immun. 70: 6904-6910 [Abstract] [Full Text]  
• McCabe, D., Cukierman, T., Gabay, J. E. (2002). Basic Residues in Azurocidin/HBP Contribute to Both Heparin Binding and Antimicrobial Activity. J. Biol. Chem. 277: 27477-27488 [Abstract] [Full Text]  
• Lee, T. D., Gonzalez, M. L., Kumar, P., Chary-Reddy, S., Grammas, P., Pereira, H. A. (2002). CAP37, a Novel Inflammatory Mediator : Its Expression in Endothelial Cells and Localization to Atherosclerotic Lesions. Am. J. Pathol. 160: 841-848 [Abstract] [Full Text]  
• Kim, H. S., Cho, J. H., Park, H. W., Yoon, H., Kim, M. S., Kim, S. C. (2002). Endotoxin-Neutralizing Antimicrobial Proteins of the Human Placenta. J. Immunol. 168: 2356-2364 [Abstract] [Full Text]  
• Scott, M. G., Rosenberger, C. M., Gold, M. R., Finlay, B. B., Hancock, R. E. W. (2000). An {alpha}-Helical Cationic Antimicrobial Peptide Selectively Modulates Macrophage Responses to Lipopolysaccharide and Directly Alters Macrophage Gene Expression. J. Immunol. 165: 3358-3365 [Abstract] [Full Text]  
• Scott, M. G., Vreugdenhil, A. C. E., Buurman, W. A., Hancock, R. E. W., Gold, M. R. (2000). Cutting Edge: Cationic Antimicrobial Peptides Block the Binding of Lipopolysaccharide (LPS) to LPS Binding Protein. J. Immunol. 164: 549-553 [Abstract] [Full Text]  
• de Haas, C. J. C., van der Zee, R., Benaissa-Trouw, B., van Kessel, K. P. M., Verhoef, J., van Strijp, J. A. G. (1999). Lipopolysaccharide (LPS)-Binding Synthetic Peptides Derived from Serum Amyloid P Component Neutralize LPS. Infect. Immun. 67: 2790-2796 [Abstract] [Full Text]